Internal Medicine Research Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Clinical and Health Informatics Research Group, McGill University, Montr??al, Qu??bec, Canada; Department of Health Informatics, Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Argentina.
Rev Diabet Stud. 2021 Nov 1;17(2):50-56. doi: 10.1900/RDS.2021.17.50.
Stress-induced hyperglycemia is a phenomenon that occurs typically in patients hospitalized for acute disease and resolves spontaneously after regression of the acute illness. However, it can also occur in diabetes patients, a fact that is sometimes overlooked. It is thus important to make a proper diabetes diagnosis if hospitalized patients with episodes of hyperglycemia with and without diabetes are studied. To estimate the extent of the association between stress-induced hyperglycemia and in-hospital mortality in patients with hospital hyperglycemia (HH), and to explore potential differences between patients diagnosed with diabetes (HH-DBT) and those with stress-induced hyperglycemia (SH), but not diagnosed with diabetes. A cohort of adults with hospital hyperglycemia admitted to a tertiary, university hospital in Buenos Aires, Argentina, was analyzed retrospectively. In the study, 2,955 patients were included and classified for analysis as 1,579 SH and 1,376 HH-DBT. Significant differences were observed in glycemic goal (35.53% SH versus 25.80% HH-DBT, p < 0.01), insulin use rate (26.66% SH versus 46.58% HH-DBT, p < 0.01), and severe hypoglycemia rate (1.32% SH versus 1.74% HH-DBT, p < 0.01). There were no differences in hypoglycemia rate (8.23% SH versus 10.53% HH-DBT) and hospital mortality. There was no increase in risk of mortality in the SH group adjusted for age, non-scheduled hospitalization, major surgical intervention, critical care, hypoglycemia, oncological disease, cardiovascular comorbidity, and prolonged hospitalization. In this study, we observed better glycemic control in patients with SH than in those with HH-DBT, and there was no difference in hospital mortality.
应激性高血糖是一种常见于急性疾病住院患者的现象,通常在急性疾病缓解后自发消退。然而,它也可能发生在糖尿病患者中,这一事实有时被忽视。因此,如果对伴有和不伴有糖尿病的高血糖住院患者进行研究,就需要正确诊断糖尿病。
本研究旨在评估应激性高血糖与住院高血糖(HH)患者院内死亡率之间的关联程度,并探讨诊断为糖尿病(HH-DBT)和诊断为应激性高血糖(SH)但未诊断为糖尿病的患者之间的潜在差异。
本研究回顾性分析了阿根廷布宜诺斯艾利斯一家三级大学医院收治的成人住院高血糖患者队列。研究共纳入 2955 例患者,根据分析分为 1579 例 SH 和 1376 例 HH-DBT。在血糖目标(35.53% SH 与 25.80% HH-DBT,p<0.01)、胰岛素使用率(26.66% SH 与 46.58% HH-DBT,p<0.01)和严重低血糖发生率(1.32% SH 与 1.74% HH-DBT,p<0.01)方面观察到显著差异。在低血糖发生率(8.23% SH 与 10.53% HH-DBT)和院内死亡率方面无差异。在调整年龄、非计划性住院、大手术干预、重症监护、低血糖、肿瘤疾病、心血管合并症和住院时间延长后,SH 组的死亡率无增加风险。
在本研究中,我们观察到 SH 患者的血糖控制优于 HH-DBT 患者,且院内死亡率无差异。
Rev Diabet Stud. 2021-11-1
Endocrinol Diabetes Nutr (Engl Ed). 2018-12
BMC Anesthesiol. 2022-7-16
Medicina (B Aires). 2023
Curr Med Res Opin. 2010-3
Ann Intern Med. 2011-2-15
Nutr Clin Pract. 2015-10
Front Endocrinol (Lausanne). 2024
Front Endocrinol (Lausanne). 2024-2-23
Front Nutr. 2022-7-8
Diabetes Care. 2019-1
Diabetes Care. 2018-1
J Diabetes Complications. 2017-2
Diabetes Metab J. 2015-8